Top Biotechnology companies in Switzerland by Operating Income
Switzerland
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 9.77 B
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
| 2 |
USD 1.05 B
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
| 3 |
USD 375.00 M
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
| 4 |
USD 204.37 M
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
| 5 |
USD 161.49 M
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
| 6 |
USD 153.67 M
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
| 7 |
USD 99.56 M
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
| 8 |
USD 95.57 M
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
| 9 |
USD 22.81 M
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
| 10 |
USD 16.33 M
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
| 11 |
USD -11.81 M
|
Dec. 31, 2023 | USD 2.03 | -1.93% |
|
Switzerland |
|
| 12 |
USD -12.21 M
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
| 13 |
USD -15.67 M
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
| 14 |
USD -40.25 M
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
|
| 15 |
USD -54.12 M
|
Dec. 31, 2023 | USD 46.50 | 2.74% |
|
Switzerland |
|
| 16 |
USD -63.69 M
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
| 17 |
USD -72.58 M
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 18 |
USD -95.87 M
|
Dec. 31, 2023 | USD 22.44 | 0.27% |
|
Switzerland |
|
| 19 |
USD -165.99 M
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 20 |
USD -210.77 M
|
Dec. 31, 2023 | USD 2.41 | 0.50% |
|
Switzerland |
|
| 21 |
USD -222.54 M
|
Dec. 31, 2023 | USD 38.36 | -1.26% |
|
Switzerland |
|
| 22 |
USD -548.56 M
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
Frequently Asked Questions
-
Which Biotechnology company in Switzerland has the highest Operating Income ?
The Biotechnology company in Switzerland with the highest Operating Income is Novartis AG (Swiss Stock Exchange: NOVN.SW) at USD 9.77 B.
-
Which Biotechnology company in Switzerland has the lowest Operating Income ?
The Biotechnology company in Switzerland with the lowest Operating Income is DSM-Firmenich AG (Amsterdam Stock Exchange: DSFIR.AS) at USD -548.56 M.
-
What are the top 10 Biotechnology companies in Switzerland by Operating Income ?
The top 10 Biotechnology companies in Switzerland by Operating Income are Novartis AG, Lonza Group AG, Sandoz Group AG, Siegfried Holding AG, Tecan Group AG, Bachem Holding AG, Dottikon Es Holding AG, Ypsomed Holding AG, Basilea Pharmaceutica AG and Metall Zug AG.
-
What are the bottom 10 Biotechnology companies in Switzerland by Operating Income ?
The bottom 10 Biotechnology companies in Switzerland by Operating Income are DSM-Firmenich AG, CRISPR Therapeutics AG, Meyer Burger Technology AG, ADC Therapeutics SA, Oculis Holding AG, Molecular Partners AG, AC Immune SA, MoonLake Immunotherapeutics, PolyPeptide Group AG and Kuros Biosciences AG.